Urol. 180(2): 520-524. 12. Chamie K, Saigal S, Lai J et al. (2011) Compliance with guidelines for patients with bladder cancer: variation in the delivery of care. Cancer 117(4):5392-5401. 13. Higano CS, Schellhammer PF, Small EJ, Burch PA, Nemunaitis J, Yuh L, et al. Integrated data from 2 randomized, double-blind, placebo-controlled, phase 3 trials of active cellular immunotherapy with sipuleucel-T in advanced prostate cancer. Cancer.